Voss Capital and Affiliates Acquire Additional Shares in Rein Therapeutics

Voss Capital, LP, along with its affiliates Voss Value Master Fund, LP, Voss Value-Oriented Special Situations Fund, LP, Voss Advisors GP, LLC, and Travis W. Cocke, have acquired additional shares in Rein Therapeutics, Inc. (RNTX). The transactions occurred between October 24 and October 28, 2025, with shares purchased at prices ranging from $1.3300 to $1.4000. The total shares acquired during this period amounted to 301,050, increasing their collective ownership to over 10% of the company's outstanding shares. The acquisitions were made in multiple transactions, and the reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.